Graeme Eisenhofer
#109,977
Most Influential Person Now
Researcher
Graeme Eisenhofer's AcademicInfluence.com Rankings
Graeme Eisenhofercomputer-science Degrees
Computer Science
#4130
World Rank
#4346
Historical Rank
Computational Linguistics
#337
World Rank
#342
Historical Rank
Machine Learning
#717
World Rank
#727
Historical Rank
Artificial Intelligence
#919
World Rank
#936
Historical Rank
Download Badge
Computer Science
Graeme Eisenhofer's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Graeme Eisenhofer Influential?
(Suggest an Edit or Addition)Graeme Eisenhofer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. (2014) (1827)
- Biochemical diagnosis of pheochromocytoma: which test is best? (2002) (1113)
- Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine (2004) (862)
- Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. (1990) (816)
- Pheochromocytoma: recommendations for clinical practice from the First International Symposium (2007) (610)
- Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma (2001) (574)
- Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. (1986) (500)
- Cardiac sympathetic nerve function in congestive heart failure. (1996) (439)
- Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. (2003) (411)
- Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans (2003) (384)
- Phaeochromocytoma (2005) (366)
- The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. (2001) (352)
- Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. (2009) (338)
- Malignant pheochromocytoma: current status and initiatives for future progress. (2004) (320)
- Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. (2007) (318)
- Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. (1999) (312)
- Sympathetic cardioneuropathy in dysautonomias. (1997) (306)
- Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. (2012) (304)
- High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. (2006) (296)
- Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. (1992) (294)
- Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. (2011) (288)
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
- Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. (2001) (283)
- Substantial production of dopamine in the human gastrointestinal tract. (1997) (283)
- Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. (2007) (271)
- Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. (1997) (267)
- Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. (1988) (238)
- Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. (2003) (234)
- Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. (2000) (232)
- Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake (1993) (230)
- Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. (2012) (229)
- Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. (1998) (229)
- Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. (1994) (216)
- Cardiovascular manifestations of phaeochromocytoma (2011) (214)
- Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. (2005) (206)
- Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. (1993) (194)
- Dysautonomias: Clinical Disorders of the Autonomic Nervous System (2002) (191)
- 6-[18F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma (2001) (191)
- Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. (2004) (190)
- In vivo measurement of neuronal uptake of norepinephrine in the human heart. (1988) (182)
- Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. (1995) (180)
- Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. (2000) (177)
- Increased sympathetic nerve activity in renovascular hypertension. (1999) (174)
- Clinical review: Current treatment of malignant pheochromocytoma. (2007) (173)
- Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. (2005) (170)
- Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. (2010) (168)
- SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) (2015) (167)
- Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. (2015) (163)
- Plasma Metanephrines in the Diagnosis of Pheochromocytoma (1995) (158)
- Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. (2011) (158)
- Functional imaging of endocrine tumors: role of positron emission tomography. (2004) (157)
- Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma (2001) (156)
- Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. (2002) (155)
- Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. (2005) (149)
- Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. (1996) (148)
- Laboratory evaluation of pheochromocytoma and paraganglioma. (2014) (146)
- Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. (1991) (136)
- Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. (1995) (136)
- Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine (1992) (131)
- Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2020) (129)
- Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. (2009) (129)
- Biochemical diagnosis of pheochromocytoma. (2004) (128)
- Positron emission tomographic imaging of cardiac sympathetic innervation and function. (1990) (128)
- Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? (1995) (121)
- Catecholamine Synthesis is Mediated by Tyrosinase in the Absence of Tyrosine Hydroxylase (1999) (120)
- Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension (2003) (117)
- Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension. (2020) (116)
- Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas (2016) (116)
- Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. (2008) (116)
- A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. (1996) (116)
- Is supine rest necessary before blood sampling for plasma metanephrines? (2007) (114)
- Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. (2014) (112)
- The Effects of Carbidopa on Uptake of 6-18F-Fluoro-l-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma (2007) (111)
- Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension (1993) (111)
- An LC–MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism (2015) (110)
- Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism. (2016) (109)
- Mesenteric Organ Production, Hepatic Metabolism, and Renal Elimination of Norepinephrine and Its Metabolites in Humans (1996) (108)
- Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification (2012) (106)
- Cardiac sympathetic denervation preceding motor signs in Parkinson disease (2007) (106)
- Effect of ethanol ingestion on plasma vasopressin and water balance in humans. (1982) (105)
- Sources and physiological significance of plasma dopamine sulfate. (1999) (104)
- 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells (2000) (104)
- Biochemical evidence of sympathetic hyperactivity in human hypertension. (1991) (104)
- Utility of plasma free metanephrines for detecting childhood pheochromocytoma. (2002) (103)
- Biochemical Diagnosis and Localization of Pheochromocytoma (2006) (103)
- Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes (2002) (101)
- Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine (2019) (98)
- Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas (2017) (98)
- Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity. (1991) (97)
- Update on Modern Management of Pheochromocytoma and Paraganglioma (2017) (97)
- Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. (2018) (97)
- Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. (2008) (96)
- Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. (1993) (96)
- Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. (1988) (96)
- Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2014) (95)
- Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma (2013) (95)
- Downregulation of metastasis suppressor genes in malignant pheochromocytoma (2005) (94)
- Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status (2017) (94)
- Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. (1989) (93)
- Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. (2011) (92)
- Pheochromocytoma as an Endocrine Emergency (2003) (92)
- Plasma norepinephrine pharmacokinetics during mental challenge. (1987) (92)
- Neuronal source of plasma dihydroxyphenylalanine. (1987) (89)
- Dopamine sulphate: an enigma resolved. (1999) (89)
- Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. (2008) (89)
- Pheochromocytoma – update on disease management (2012) (89)
- Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover. (1996) (86)
- Adverse Drug Reactions in Patients with Phaeochromocytoma (2007) (85)
- Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4‐dihydroxyphenylacetaldehyde (2000) (85)
- Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma (2013) (85)
- Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. (2001) (83)
- Update on pediatric pheochromocytoma (2009) (83)
- Plasma metanephrines in renal failure. (2005) (82)
- Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites. (2013) (82)
- Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour (2005) (80)
- Pheochromocytoma: Diagnosis and management update (2004) (80)
- Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice (2007) (80)
- Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study (2020) (79)
- Increased norepinephrine spillover into the jugular veins in essential hypertension. (1992) (78)
- Pubertal and gender-related changes in the sympathoadrenal system in healthy children. (2002) (78)
- Use of 6‐[18F]‐fluorodopamine positron emission tomography (PET) as first‐line investigation for the diagnosis and localization of non‐metastatic and metastatic phaeochromocytoma (PHEO) (2009) (77)
- Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2) (2003) (76)
- Tyrosinase: a developmentally specific major determinant of peripheral dopamine (2003) (76)
- Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation. (1995) (75)
- Plasma Norepinephrine Responses to Head‐Up Tilt Are Misleading in Autonomic Failure (1992) (75)
- The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. (2001) (75)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis (2020) (74)
- Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. (1989) (73)
- Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma (2017) (72)
- The effects of acute and chronic ingestion of ethanol on the autonomic nervous system. (1986) (72)
- Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC‐associated factor X (2014) (71)
- Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. (2009) (71)
- Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. (1989) (70)
- Plasma Metanephrines in the Diagnosis of Pheochromocytoma (1996) (70)
- New Advances in the Biochemical Diagnosis of Pheochromocytoma (2002) (69)
- Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. (2008) (69)
- The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. (2007) (69)
- 1,111 Patients with Adrenal Incidentalomas Observed at a Single Endocrinological Center (2006) (67)
- Plasma Metanephrine for Assessing the Selectivity of Adrenal Venous Sampling (2013) (67)
- Catecholamines : bridging basic science with clinical medicine (1998) (67)
- Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. (2004) (67)
- Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. (2008) (66)
- Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review (2017) (65)
- Adrenomedullary function is severely impaired in 21‐hydroxylase‐deficient mice (1999) (64)
- Diagnosis and localization of pheochromocytoma. (2004) (64)
- Subclinical phaeochromocytoma. (2012) (63)
- Gene Expression Profiling of Benign and Malignant Pheochromocytoma (2006) (62)
- Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. (2004) (62)
- Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. (2006) (61)
- Effects of ethanol on plasma catecholamines and norepinephrine clearance (1983) (61)
- Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. (1991) (61)
- Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer–Predisposing Mutations in Pheochromocytomas and Paragangliomas (2017) (61)
- Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. (2014) (60)
- A "pheo" lurks: novel approaches for locating occult pheochromocytoma. (2001) (60)
- Neuronal Reuptake of Norepinephrine and Production of Dihydroxyphenyiglycol by Cardiac Sympathetic Nerves in the Anesthetized Dog (1991) (60)
- Free or total metanephrines for diagnosis of pheochromocytoma: what is the difference? (2001) (59)
- Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines? (2003) (59)
- Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations (2009) (59)
- Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. (1989) (58)
- Personalized Management of Pheochromocytoma and Paraganglioma (2021) (58)
- Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. (2017) (57)
- Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma. (1986) (56)
- Diagnostic Localization of Pheochromocytoma (2002) (56)
- Mechanism of Peripheral Noradrenergic Stimulation by Clozapine (1998) (56)
- Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo. (2000) (56)
- Adipocyte-Specific Hypoxia-Inducible Factor 2α Deficiency Exacerbates Obesity-Induced Brown Adipose Tissue Dysfunction and Metabolic Dysregulation (2015) (55)
- Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. (2014) (54)
- Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome. (2018) (54)
- Pheochromocytoma: Rediscovery as a catecholamine-metabolizing tumor (2003) (54)
- PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics. (2017) (53)
- DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers (2015) (53)
- Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. (2002) (53)
- Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. (1991) (52)
- Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. (2005) (52)
- Regional homovanillic acid production in humans. (1993) (52)
- Simultaneous determination of plasma noradrenaline and adrenaline kinetics (1990) (51)
- Increased cardiac sympathetic drive in renovascular hypertension (2002) (51)
- Mutations associated with succinate dehydrogenase d‐related malignant paragangliomas (2008) (51)
- Comparison of 18 F-Fluoro-L-DOPA, 18 F-Fluoro-Deoxyglucose, and 18 F-Fluorodopamine PET and 123 I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma (2009) (51)
- Leaky Catecholamine Stores: Undue Waste or a Stress Response Coping Mechanism? (2004) (49)
- Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma (2013) (48)
- Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. (1989) (48)
- Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol. (1985) (48)
- Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (48)
- Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. (1995) (47)
- Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism (2018) (47)
- Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy (2016) (47)
- Dopamine Produced by the Stomach May Act as a Paracrine/ Autocrine Hormone in the Rat (1998) (46)
- Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma (2007) (46)
- Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes. (1999) (46)
- Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. (1994) (46)
- Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. (2005) (46)
- Differences in the neuronal removal of circulating epinephrine and norepinephrine. (1990) (46)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (45)
- Beta-adrenoceptor responsiveness and plasma catecholamines as determinants of cardiovascular reactivity to mental stress. (1985) (45)
- Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues (2009) (45)
- Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. (2016) (44)
- Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma (2019) (44)
- Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. (1997) (43)
- Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise. (2007) (43)
- Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients (2020) (43)
- Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. (1991) (43)
- The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now (2014) (43)
- Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. (1998) (42)
- Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma. (2015) (42)
- Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas. (2019) (42)
- Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens. (1987) (42)
- Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. (2000) (41)
- SYMPATHETIC AND RENIN‐ANGIOTENSIN ACTIVATION DURING GRADED HYPOVOLEMIA IN PIGS: IMPACT ON MESENTERIC PERFUSION AND DUODENAL MUCOSAL FUNCTION (1997) (41)
- Non-neuronal dopamine in the gastrointestinal system. (1999) (41)
- Vasopressin concentrations during alcohol withdrawal. (1985) (41)
- Mortality Associated with Phaeochromocytoma (2013) (41)
- Clinical utility of chromogranin A in SDHx‐related paragangliomas (2014) (41)
- Source and Physiological Significance of Plasma 3,4‐Dihydroxyphenylalanine in the Rat (1988) (40)
- Dopamine lesion‐induced changes in subthalamic nucleus activity are not associated with alterations in firing rate or pattern in layer V neurons of the anterior cingulate cortex in anesthetized rats (2007) (40)
- Norepinephrine spillover from human adipose tissue before and after a 72-hour fast. (2002) (40)
- Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. (2008) (39)
- Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine. (2019) (39)
- Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. (2019) (39)
- Principles of catecholamine biosynthesis, metabolism and release. (2004) (38)
- The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity (2019) (38)
- Differentiated Response of the Sympathetic Nervous System to Angiotensin-Converting Enzyme Inhibition in Hypertension (2000) (38)
- The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. (1994) (37)
- Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro (2018) (37)
- GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy (2021) (37)
- Changes in morphology and function of adrenal cortex in mice fed a high-fat diet (2014) (37)
- Endocrine Conditions and COVID-19 (2020) (36)
- Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features. (2013) (36)
- Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. (1991) (36)
- Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. (1991) (34)
- Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome (2009) (34)
- CHLAMYDIA INFECTION (2001) (34)
- PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas. (2016) (33)
- Sympathoadrenal medullary system and stress. (1988) (33)
- Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure (1991) (33)
- Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation. (1996) (33)
- Deficient catecholamine release as the basis of orthostatic hypotension in pernicious anaemia. (1982) (33)
- Hypotension in a woman with a metastatic dopamine-secreting carotid body tumor. (2003) (33)
- Usefulness of Standardized Uptake Values for Distinguishing Adrenal Glands with Pheochromocytoma from Normal Adrenal Glands by Use of 6-18F-Fluorodopamine PET (2007) (33)
- Selegiline in ADHD Adults: Plasma Monoamines and Monoamine Metabolites (1997) (32)
- Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics. (2015) (32)
- Multimodal Somatostatin Receptor Theranostics Using [64Cu]Cu-/[177Lu]Lu-DOTA-(Tyr3)octreotate and AN-238 in a Mouse Pheochromocytoma Model (2016) (32)
- Splanchnic circulation and regional sympathetic outflow during peroperative PEEP ventilation in humans. (1999) (32)
- Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. (2013) (32)
- Chromaffin cells: the peripheral brain (2012) (32)
- Norepinephrine spillover in forearm and subcutaneous adipose tissue before and after eating. (1999) (32)
- Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients. (1999) (31)
- Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog (1992) (30)
- Screening for Pheochromocytomas and Paragangliomas (2012) (30)
- Candidate Genes Associated With Malignant Pheochromocytomas by Genome-Wide Expression Profiling (2009) (30)
- Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma. (2010) (30)
- Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging (2015) (29)
- Choice of biochemical test for diagnosis of pheochromocytoma: Validation of plasma metanephrines (2002) (29)
- Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. (1998) (29)
- Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism (2020) (29)
- Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. (1998) (28)
- Transcriptional Regulation of Phenylethanolamine N‐Methyltransferase in Pheochromocytomas from Patients with von Hippel–Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 (2006) (28)
- Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas. (2013) (27)
- Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine. (1997) (27)
- Elevated Steroid Hormone Production in the db/db Mouse Model of Obesity and Type 2 Diabetes (2016) (27)
- Opposite changes in turnover of noradrenaline and dopamine in the CNS of ethanol-dependent mice (1990) (27)
- Analytical differences between the determination of plasma catecholamines by liquid chromatography with electrochemical detection and by radioenzymatic assay. (1986) (27)
- Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells (2012) (27)
- Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma (2019) (27)
- Neuroendocrine cancer: Closing the GAPP on predicting metastases (2014) (26)
- Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats. (1999) (26)
- Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma (2005) (26)
- Catecholamines and Serotonin (2012) (26)
- Effects of Risperidone on the Peripheral Noradrenegic System in Patients with Schizophrenia: A Comparison with Clozapine and Placebo (2002) (26)
- Subtyping of Patients with Primary Aldosteronism: An Update (2017) (26)
- Hemodynamic, sympathetic and angiotensin II responses to PEEP ventilation before and during administration of isoflurane (1997) (26)
- Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice (2002) (26)
- Plasma steroid profiles in subclinical compared to overt adrenal Cushing's syndrome. (2019) (26)
- Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine (2014) (26)
- Interference from 3-O-methyldopa with ultra-high performance LC-MS/MS measurements of plasma metanephrines: chromatographic separation remains important. (2015) (26)
- Pheochromocytoma and Pregnancy. (2019) (25)
- The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids. (2017) (25)
- Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat (1996) (25)
- Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat (1996) (25)
- Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens. (1988) (24)
- The role of regulated necrosis in endocrine diseases (2021) (24)
- An assessment of biochemical tests for the diagnosis of pheochromocytoma (2007) (24)
- Classification of microadenomas in patients with primary aldosteronism by steroid profiling (2019) (23)
- Cardiac Uptake-1 Inhibition by High Circulating Norepinephrine Levels in Patients with Pheochromocytoma (2004) (23)
- Impact of LC-MS/MS on the laboratory diagnosis of catecholamine-producing tumors (2016) (23)
- Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice. (2000) (23)
- Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma. (2014) (23)
- Reducing agents induce thrombomodulin shedding in human endothelial cells. (2010) (23)
- Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin (2019) (22)
- Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing. (2005) (22)
- Dihydroxyphenylglycol and dihydroxymandelic acid during intravenous infusions of noradrenaline. (1987) (22)
- Hepatomesenteric release and removal of norepinephrine in swine. (1995) (22)
- Sympathetic nerve function--assessment by radioisotope dilution analysis. (2005) (22)
- Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs (1992) (22)
- Adrenal cortical and chromaffin stem cells: Is there a common progeny related to stress adaptation? (2017) (21)
- Plasma Catechols - What Do They Mean? (1988) (21)
- Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. (1991) (21)
- Pheochromocytoma: Diagnosis, Localization, and Treatment (2007) (21)
- Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells (2015) (20)
- Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart. (1997) (20)
- Effects of ethanol ingestion on alpha-adrenoceptor-mediated circulatory responses in man. (1984) (20)
- Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. (2010) (20)
- Adrenal medullary dysfunction as a feature of obesity (2017) (20)
- HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. (2020) (20)
- Clinical Catecholamine Neurochemistry: A Legacy of Julius Axelrod (2006) (20)
- Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter (2000) (20)
- Hypertensive crisis in pregnancy due to a metamorphosing pheochromocytoma with postdelivery Cushing's syndrome (2018) (20)
- Autonomic Nervous System Function in Rheumatoid Arthritis (2012) (20)
- Effects of ethanol on cardiovascular and catecholamine responses to mental stress. (1986) (20)
- A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis (2011) (20)
- Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease? (2018) (19)
- Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats (1994) (19)
- Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma. (2019) (19)
- Time matters – Acute stress response and glucocorticoid sensitivity in early multiple sclerosis (2014) (19)
- Current Treatment of Malignant Pheochromocytoma (2007) (19)
- Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells (2019) (19)
- A Transgenic Mouse Model of Pacak–Zhuang Syndrome with An Epas1 Gain-of-Function Mutation (2019) (19)
- Differential Effects of Chemical Sympathectomy on Expression and Activity of Tyrosine Hydroxylase and Levels of Catecholamines and DOPA in Peripheral Tissues of Rats (2004) (19)
- Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma (2008) (19)
- Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. (2008) (19)
- Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches (2019) (19)
- Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1. (2018) (19)
- Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases. (2019) (19)
- Differentiation of Chromaffin Progenitor Cells to Dopaminergic Neurons (2012) (19)
- Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography. (2002) (19)
- Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells (2018) (19)
- Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster (2017) (18)
- Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats. (1993) (18)
- Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy. (2019) (18)
- Tyrosine hydroxylase assay for detection of low levels of enzyme activity in peripheral tissues. (1997) (18)
- Growth hormone, vasopressin, cortisol, and catecholamine responses to insulin hypoglycemia in alcoholics. (1984) (18)
- The incidentally discovered adrenal mass. (2007) (18)
- Aldose reductase: An aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia (2002) (17)
- Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures. (2019) (17)
- In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma. (2014) (17)
- BRAIN WATER DURING ALCOHOL WITHDRAWAL (1982) (17)
- Expression and shedding of endothelial protein C receptor in prostate cancer cells (2011) (17)
- Plasma‐free vs deconjugated metanephrines for diagnosis of phaeochromocytoma (2013) (17)
- Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. (1998) (17)
- Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. (2007) (17)
- Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits. (1991) (17)
- Catecholamine Phenotyping: Clues to the Diagnosis, Treatment, and Pathophysiology of Neurogenetic Disorders (1996) (17)
- PNMT transgenic mice have an aggressive phenotype. (2005) (17)
- Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. (2007) (17)
- Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma (2020) (17)
- Effects of ethanol ingestion on blood pressure reactivity. (1987) (17)
- Unexplained Symptomatic Paroxysmal Hypertension in Pseudopheochromocytoma (2008) (16)
- Pharmacologic and tracer methods to study sympathetic function in primary hypertension. (1989) (16)
- Cardiac sympathetic denervation preceding motor signs in Parkinson disease (2009) (16)
- Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma. (2014) (16)
- Increased spillover and reduced clearance both contribute to rise in plasma catecholamines after birth in lambs. (1996) (16)
- Effects of Duloxetine on Norepinephrine and Serotonin Transporter Activity in Healthy Subjects (2014) (16)
- Surgery: Risks of hemodynamic instability in pheochromocytoma (2010) (16)
- Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits (1990) (16)
- Diagnostic imaging of pheochromocytoma. (2004) (16)
- Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. (2020) (16)
- Cancer Stem Cells in Pheochromocytoma and Paraganglioma (2020) (16)
- Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. (1995) (15)
- Computational analysis of liquid chromatography-tandem mass spectrometric steroid profiling in NCI H295R cells following angiotensin II, forskolin and abiraterone treatment (2016) (15)
- Steroid Hormone Production in Patients with Aldosterone Producing Adenomas (2015) (15)
- High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet? (2007) (15)
- [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine]. (2013) (15)
- Genetic Screening for von Hippel-Lindau Gene Mutations in Non-syndromic Pheochromocytoma: Low Prevalence and False-positives or Misdiagnosis Indicate a Need for Caution (2012) (15)
- Pheochromocytoma: an endocrine stress mimicking disorder. (2008) (15)
- Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma. (2014) (15)
- Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas (2020) (15)
- Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma (2009) (15)
- 123I-MIBG scintigraphy of catecholamine systems: impediments to applications in clinical medicine (2000) (15)
- Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism—a Review (2019) (15)
- Effects of ethanol ingestion on thirst and fluid consumption in humans. (1983) (14)
- The role of 6-[ 18 F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel–Lindau syndrome (2007) (14)
- Rapid circulatory clearances and half‐lives of plasma free metanephrines (2012) (14)
- Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome. (2012) (14)
- Splanchnic and Renal Sympathetic Activity in Relation to Hemodynamics During Isoflurane Administration in Pigs (1995) (14)
- Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome. (2007) (14)
- Pulmonary clearance and release of norepinephrine and epinephrine in newborn lambs. (1997) (14)
- Metabolic impact of pheochromocytoma/paraganglioma: Targeted metabolomics in patients before and after tumor removal. (2019) (13)
- Dopaminergic characteristics of isolated parietal cells from rats (1997) (13)
- Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. (2000) (13)
- Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. (1992) (13)
- Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma. (2012) (13)
- Direct effect of dehydroepiandrosterone sulfate (DHEAS) on PC-12 cell differentiation processes (2011) (12)
- Genetic deficiencies of monoamine oxidase enzymes: a key to understanding the function of the enzymes in humans. (1998) (12)
- Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure. (1999) (12)
- Clinical Presentation of Pheochromocytoma (2008) (12)
- Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours (2019) (12)
- Cardiac noradrenergic function one year following cardiac transplantation. (1993) (12)
- ADRENALINE RELEASE BY THE HUMAN HEART (1991) (12)
- Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension (2020) (12)
- Differential Effects of Central and Peripheral Desipramine on Sympathoadrenal Function and Heart Rate in Conscious Rabbits (1991) (11)
- Dehydroepiandrosterone-sulphate (DHEA-S) promotes neuroendocrine differentiation of chromaffin pheochromocytoma PC12 cells (2009) (11)
- Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats. (2016) (11)
- Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas. (2019) (11)
- Dipping in Ambulatory Blood Pressure Monitoring Correlates With Overnight Urinary Excretion of Catecholamines and Sodium (2016) (11)
- Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine (2019) (11)
- HIF1α is a direct regulator of steroidogenesis in the adrenal gland (2021) (10)
- Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (10)
- Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma (2021) (10)
- Pheochromocytoma presenting as takotsubo-like cardiomyopathy following delivery. (2014) (10)
- DISSOCIATION BETWEEN CORTICOTROPHIN AND CATECHOLAMINE RESPONSES TO ISOPRENALINE IN HUMANS (1987) (10)
- Novel methods in adrenal research: a metabolomics approach (2019) (10)
- Intracoronary blockade of angiotensin-converting enzyme in humans: interaction with cardiac sympathetic neurotransmission? (1997) (10)
- Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery. (2020) (10)
- Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine. (1991) (10)
- Optimized Reference Intervals for Plasma Free Metanephrines in Patients With CKD. (2018) (10)
- Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case report. (2014) (10)
- Implications of plasma levels of catechols in the evaluation of sympathoadrenomedullary function. (1989) (10)
- Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells (2013) (10)
- The longevity gene mIndy (I’m Not Dead, Yet) affects blood pressure through sympathoadrenal mechanisms (2021) (9)
- Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma (2011) (9)
- Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging (2018) (9)
- The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy (2021) (9)
- Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia. (2020) (9)
- Is adrenaline released by sympathetic nerves in man? (1991) (9)
- Cure of neuroendocrine carcinoma by peptide receptor radionuclide therapy. (2008) (9)
- High-Throughput Molecular and Histopathologic Profiling of Tumor Tissue in a Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery (2012) (9)
- A Defined, Controlled Culture System for Primary Bovine Chromaffin Progenitors Reveals Novel Biomarkers and Modulators (2014) (9)
- Simultaneous determination of endogenous catechols and exogenous 2- and 6-fluorinated catechols in tissue and plasma using liquid chromatography with electrochemical detection. (1988) (8)
- Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome – a systematic review (2020) (8)
- Utility of plasma free metanephrines in diagnosis of factitious pheochromocytoma. (2006) (8)
- Preservation of urine free catecholamines and their free O-methylated metabolites with citric acid as an alternative to hydrochloric acid for LC-MS/MS-based analyses (2016) (8)
- Pheochromocytoma and Paraganglioma: Recent Progress and New Vistas for Improved Patient Care (2012) (8)
- Steroid Profiling for Adrenocortical Disorders: A Pathway for Omics-Based Diagnostics. (2017) (8)
- Biochemical Diagnosis of Pheochromocytoma, a Rediscovered Catecholamine-Metabolizing Tumor. (2018) (8)
- Regulation of thrombomodulin expression in prostate cancer cells. (2012) (8)
- Supine or Sitting? Economic and other considerations for use of plasma metanephrines for diagnosis of phaeochromocytoma (2015) (8)
- The influence of aging on the plasma concentration and renal clearance of homovanillic acid (1994) (8)
- Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase (1996) (8)
- Concentrations of noradrenaline at neuronal uptakes sites during sympathetic nervous inhibition and activation in rabbits (1993) (8)
- Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster12 (2016) (8)
- Volumetric Modeling of Adrenal Gland Size in Primary Bilateral Macronodular Adrenocortical Hyperplasia. (2020) (8)
- Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine. (2021) (8)
- Left ventricular norepinephrine and epinephrine kinetics at birth in lambs. (1997) (8)
- Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma (2014) (8)
- Phaeochromocytoma — advances through science, collaboration and spreading the word (2020) (8)
- COMPARISON OF NORADRENALINE AND ISOPRENALINE REMOVAL IN THE CANINE HINDLIMB AND KIDNEY (1986) (8)
- Pheochromocytoma: recent advances and speed bumps in the road to further progress. (2006) (8)
- The Catalytic Subunit β of PKA Affects Energy Balance and Catecholaminergic Activity (2019) (7)
- Overnight/first morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: Is this an option? (2020) (7)
- Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background (2019) (7)
- Adrenergic and Noradrenergic Plasma Levels in Lesch-Nyhan Disease (2000) (7)
- [Pheochromocytoma: update on diagnosis and therapy]. (2014) (7)
- Effects of Nebivolol on Haemodynamics, Cardiac Dimensions and Function, Cardiovascular Reflexes and Biochemical Measures of Sympathetic Activity in Normal Human Subjects (1991) (7)
- Is there still a place for adrenal venous sampling in the diagnostic localization of pheochromocytoma? (2011) (7)
- No effect of ethanol ingestion on beta-adrenoceptor-mediated circulatory responses to isoprenaline in man. (1985) (7)
- Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features. (2016) (7)
- Gene Expression Profiling of Rat Pheochromocytoma (2006) (7)
- The Adrenal Gland: Central Relay in Health and Disease (2019) (7)
- Hypoxia-inducible Factor 2α: A Key Player in Tumorigenesis and Metastasis of Pheochromocytoma and Paraganglioma? (2021) (7)
- Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference. (2020) (7)
- Sympathetic nerve function (2005) (7)
- Genetics and the Clinical Approach to Paragangliomas (2014) (6)
- Clues to the diagnosis of pheochromocytoma from the differential tissue metabolism of catecholamines. (1998) (6)
- Plasma steroid profiling in patients with adrenal incidentaloma. (2021) (6)
- Steroid metabolomics: machine learning and multidimensional diagnostics for adrenal cortical tumors, hyperplasias, and related disorders (2019) (6)
- Sympathetic Nervous System Physiology and Pathophysiology in Coping with the Environment (2011) (6)
- Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon? (1998) (6)
- Current Trends in Biochemical Diagnosis of Pheochromocytoma (2008) (6)
- Report from the HarmoSter study: impact of calibration on comparability of LC-MS/MS measurement of circulating cortisol, 17OH-progesterone and aldosterone (2022) (6)
- Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study (2022) (6)
- In vivo kinetics of catecholamines. (1994) (6)
- [Endocrine hypertension: new aspects and developments]. (2012) (6)
- Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. (2020) (6)
- Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart. (1997) (6)
- Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2013) (5)
- HIF2α regulates the synthesis and release of epinephrine in the adrenal medulla (2021) (5)
- Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics. (2020) (5)
- Peripheral Dopamine Systems (2004) (5)
- Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure. (2001) (5)
- No improvement in ethanol-induced memory deficits after administration of a vasopressin analog. (1985) (5)
- Phäochromozytom: Diagnostik und Therapie (2014) (5)
- Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: Morphologic and radiopharmacologic characterization (2019) (5)
- Generation and characterization of a mitotane-resistant adrenocortical cell line (2020) (5)
- Metabolomic distinction of microvascular effects of lipoprotein apheresis--a pilot study. (2013) (5)
- Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine (2022) (5)
- Strain-specific metastatic phenotypes in pheochromocytoma allograft mice (2018) (5)
- Maternal and fetal factors which influence cord blood glucose levels in term infants delivered by cesarean section (2014) (5)
- Adrenal Hormone Interactions and Metabolism: A Single Sample Multi-Omics Approach (2021) (4)
- Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review (2021) (4)
- Adrenal Vein Catecholamine Levels and Ratios: Reference Intervals Derived from Patients with Primary Aldosteronism (2015) (4)
- Regional and total body changes in sympathoadrenal activity in response to eating (2000) (4)
- Double stable isotope ultra performance liquid chromatographic-tandem mass spectrometric quantification of tissue content and activity of phenylethanolamine N-methyltransferase, the crucial enzyme responsible for synthesis of epinephrine (2013) (4)
- 7D.07: RETINAL ARTERIOLAR STRUCTURE IN PATIENTS WITH PHEOCHROMOCYTOMA (2015) (4)
- Plasma levels of catechols during reflexive changes in sympathetic nerve activity (1989) (4)
- Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? (2021) (4)
- Simultaneous liquid-chromatographic determination of plasma catecholamines and metabolites. (2009) (4)
- Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion (2021) (4)
- A steady state system for in vitro evaluation of steroidogenic pathway dynamics: Application for CYP11B1, CYP11B2 and CYP17 inhibitors (2019) (4)
- Genetic markers for the diagnosis and prognosis of pheochromocytoma (2009) (4)
- Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. (2022) (4)
- Compensation for chronic oxidative stress in ALADIN null mice (2017) (3)
- Impact of Aldosterone Synthase Inhibitor FAD286 on Steroid Hormone Profile in Human Adrenocortical Cells (2017) (3)
- Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. (2022) (3)
- Development of a Function-Integrative Sleeve for Medical Applications (2019) (3)
- Arterio-venous differences in cord levels of catecholamines, glucose, lactate and blood gases (2016) (3)
- THE LONGEVITY GENE MINDY (I'M NOT DEAD, YET) AFFECTS BLOOD PRESSURE THROUGH SYMPATHOADRENAL MECHANISMS (2018) (3)
- Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18 F-Fluorodeoxyglucose ( 18 F-FDG) (2012) (3)
- The Aldosterone Synthase Inhibitor FAD286 is Suitable for Lowering Aldosterone Levels in ZDF Rats but not in db/db Mice (2017) (3)
- Current approaches and new advances in endocrine hypertension (2002) (3)
- Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment. (2020) (3)
- Diagnostik des Phäochromozytoms (2000) (2)
- Neue Entwicklungen bei Nebennierenerkrankungen (2011) (2)
- HIF1α is an essential regulator of steroidogenesis in the adrenal gland (2020) (2)
- Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma (2022) (2)
- Catecholamines and Adrenergic Receptors (2008) (2)
- Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles (2020) (2)
- Current Trends in Genetics of Pheochromocytoma (2008) (2)
- Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma (2021) (2)
- A pedunculated aldosterone‐producing adenoma drained by an extra vein causing puzzling results of adrenal vein sampling (2018) (2)
- Pheochromocytoma or Münchausen syndrome: the masquerade is up (2010) (2)
- Preanalytical considerations and out-patient vs in-patient tests of plasma metanephrines to diagnose pheochromocytoma. (2022) (2)
- Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (2)
- Angpt2/Tie2 autostimulatory loop controls tumorigenesis (2022) (2)
- Imaging vs Biochemical Testing for Pheochromocytoma—Reply (2002) (2)
- Pheochromocytoma (2008) (2)
- Future Trends and Perspectives (2008) (2)
- Functional significance of germline EPAS1 variants (2020) (2)
- Blood pressure profile, sympathetic nervous system activity and subclinical target organ damage in patients with polycythemia vera. (2020) (2)
- Ethanol-induced inhibition of the drinking response to hypertonic saline in the rat (1985) (2)
- Biochemical screening for phaeochromocytoma using plasma free metanephrines: utility beyond diagnosis (2011) (2)
- Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism (2022) (2)
- Chapter 110 – Pheochromocytoma (2016) (2)
- Aldo-keto reductases in norepinephrine metabolism. (1999) (2)
- Harmonization status among ten European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for steroid measurements in serum: preliminary results from the HarmoSter consortium (2019) (2)
- Measurements of plasma metanephrines by immunoassay versus LC-MS/MS for diagnosis of pheochromocytoma (2014) (2)
- Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios (2022) (2)
- Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma (2016) (2)
- Resection of Pheochromocytoma in a Patient Requiring Coronary Artery Bypass Grafting: First Things First (2016) (2)
- Endocrine Hypertensive Emergencies (2014) (2)
- Simultaneous development of pheochromocytomas in prepubertal siblings with von Hippel-Lindau syndrome. (2002) (2)
- Seasonal variations of plasma normetaneprine levels: the authors reply. (2014) (2)
- Differential Responses of Urinary Epinephrine and Norepinephrine to 24-h Shift-Work Stressor in Physicians (2020) (2)
- Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review. (2022) (2)
- Evaluation of a novel fluorescence-based animal model of pheochromocytoma for theragnostic investigations (2014) (2)
- Impact of Dietary Sodium Reduction on the Development of Obesity and Type 2 Diabetes in db/db Mice (2021) (1)
- Pierson syndrome (2020) (1)
- New Way Forward for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Tumors with an LC-MS/MS Panel of Indole Biomarkers. (2019) (1)
- Current Trends in Localization of Pheochromocytoma (2008) (1)
- Pheochromocytoma and Paraganglioma (2019) (1)
- Normetanephrine and Metanephrine (2004) (1)
- Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension (2022) (1)
- Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis. (2022) (1)
- Endokrine Hypertonie – Neuigkeiten und jüngste Entwicklungen (2012) (1)
- [PP.12.17] EVALUATION OF SELECTED PARAMETERS OF NEURO-HORMONAL ACTIVITY AND RETINAL AND INTRARENAL PERFUSION IN PATIENTS WITH POLYCYTHEMIA VERA (2016) (1)
- Plasma free versus deconjugated metanephrines for diagnosis of pheochromocytoma (2013) (1)
- Optimized procedures for testing plasma metanephrines in patients on hemodialysis (2021) (1)
- Utility of LC-MS/MS based adrenal venous steroid profiling: Should cortisol remain the gold standard for selectivity and comparisons to aldosterone? (2014) (1)
- Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. (1998) (1)
- Imaging vs biochemical testing for pheochromocytoma. Authors' reply (2002) (1)
- Relationship Between the Sympatholytic Action of Nebivolol and Hypotension (1992) (1)
- Non-neuronal dopamine in the gastro-intestinal system Sites of production and possible targets (1999) (1)
- 31 ACTIVE SURVEILLANCE OF PHEO IN VON HIPPEL-LINDAU (VHL) PATIENTS: EVALUATION OF SAFETY AND GROWTH RATES (2010) (1)
- PHEOCHROMOCYTOMA CONCEALED BY CHRONIC METHAMPHETAMINE ABUSE. (2020) (1)
- Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review (2021) (1)
- Chapter 12 – Dopaminergic Neurotransmission (2012) (1)
- Commentary on Cryptogenic Cushing Syndrome Due to a White Lie. (2020) (1)
- Hypoxia pathway proteins regulate the synthesis and release of epinephrine in the mouse adrenal gland (2020) (1)
- Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma. (2022) (1)
- Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine (2022) (1)
- Steroid Profiling as an Additional Tool to Confirm One-Sided Hormone Overproduction in Primary Aldosteronism: A Case Report (2019) (1)
- HIF2α regulates the synthesis and release of epinephrine in the adrenal medulla (2021) (1)
- Divergent relationship of body mass index with plasma norepinephrine and epinephrine (2004) (1)
- Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model (2022) (1)
- Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma (2022) (1)
- Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology (2022) (1)
- I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma (2018) (1)
- Reduced Adipose Tissue Sympathetic Nervous System (SNS) Activity in Human Obesity despite Increased Whole Body Norepinephrine Spillover (2002) (1)
- Comprar Pheochromocytoma | KAREL PACAK | 9781405149501 | Blackwell Publishing (2007) (0)
- Abstract 429: Ambulatory Blood Pressure Dipping is Significantly Related to Night/Day Urinary Norepinephrine Ratio (2013) (0)
- Novel therapeutic strategies for the treatment of pheochromocytoma (2013) (0)
- Liquid Chromatography-Tandem Mass Spectrometry for Measurement of Urine Metanephrines (2011) (0)
- Oral presentations (2008) (0)
- SUN-222 Pre- and Post-Pubertal Reference Ranges for Oxygenated Androgens in Saliva (2020) (0)
- Abstract 543: Impact of Eplerenone on Vascular Function in LOX-1 Overexpressing Mice on High-Fat Diet (2015) (0)
- Impaired blood glucose regulation during physical exercise in APS2 patients with combined Addison's disease and type 1 diabetes (2014) (0)
- Sympathoadrenal function in patients with paroxysmal hypertension (2006) (0)
- 228: A novel animal model of phaeochromocytoma for preclinical therapy evaluation (2014) (0)
- Preface (2006) (0)
- Die Diagnose des Phäochromozytoms und Paraganglioms (2013) (0)
- University of Groningen Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma (2019) (0)
- Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort (2021) (0)
- Tumor microenvironment increases migration/invasion of murine pheochromocytoma SDHB silenced spheroids (2017) (0)
- Plasma Metanephrines: the Optimal Diagnostic Tool for Pheochromocytoma? (2004) (0)
- methoxytyramine spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass (2013) (0)
- Distinct catecholamine phenotypes in hereditary pheochromocytoma (2008) (0)
- Molecular Diagnostics and Genetics (2007) (0)
- Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
- Acknowledgment to Reviewers (2020) (0)
- 995-19 The Impact of Mental Stress and α-Adrenergic Activation on the Microcirculation of Patients with Coronary Artery Disease (1995) (0)
- Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension (2021) (0)
- Phäochromozytom und Paragangliom (2016) (0)
- Means for setting and determining the blood flow plateaus (2014) (0)
- Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells (2018) (0)
- Blood sampling for metanephrines: to stick or stick and wait? (2020) (0)
- Phaeochromocytoma: a clinical chameleon (2013) (0)
- [Recent advances in adrenal diseases]. (2011) (0)
- Identification and stratification of pheochromocytomas/paragangliomas with SDHx mutations using the succinate to fumarate ratio (2014) (0)
- High-Throughput Molecular and Histopathologic Profiling of the Tumor Microenvironment in A Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery (2005) (0)
- Treatment of Pheochromocytoma (2008) (0)
- Biochemical Assessment of Pheochromocytoma and Paraganglioma. (2023) (0)
- Rapid testing in adrenal venous sampling (2013) (0)
- Genotype-Speci fi c Abnormalities in Mitochondrial Function Associate with Distinct Pro fi les of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma (2013) (0)
- Prospective prediction of germ line mutations in patients with pheochromocytomas and paragangliomas according to biochemical profiles (2015) (0)
- Labordiagnostik Katecholamin-produzierender Tumoren (2013) (0)
- Optimized procedures for diagnostic testing for pheochromocytoma and paraganglioma in patients on hemodialysis (2021) (0)
- Chapter 86 – Pheochromocytoma (2012) (0)
- S-47-2: DIAGNOSIS OF PRIMARY ALDOSTERONISM USING ARTIFICIAL INTELLIGENCE (2023) (0)
- Pheochromocytoma affecting Pregnancy: still searching the needle in the haystack? (2019) (0)
- OR03-02 Identification of a Novel Stem/Progenitor Population of the Adrenal Medulla (2020) (0)
- Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (0)
- Reference intervals of plasma catecholamines in newborns for diagnosis of Menkes disease (2011) (0)
- INNV-04. IDH MUTATION PREDICTION IN GLIOMA: A MULTIMODAL APPROACH (2019) (0)
- Diagnosis and Management of Urinary Bladder Paragangliomas: A Retrospective International Multicenter Study (2022) (0)
- Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma (2023) (0)
- SUN-LB97 Targeted Metabolomics as a Screening Tool in the Diagnosis of Endocrine Hypertension (2020) (0)
- A difficult diagnosis: pheochromocytoma or methamphetamine abuse? (2019) (0)
- [Diagnosis of pheochromocytoma]. (2000) (0)
- MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors (2020) (0)
- Report from the HarmoSter study: inter-laboratory comparison of LC-MS/MS measurements of corticosterone, 11-deoxycortisol and cortisone (2022) (0)
- Abstract 195: Establishment and validation of pheochromocytoma organoids for high-throughput drug screening (2023) (0)
- KAPITEL 32 – Phäochromozytom – Paragangliom (2010) (0)
- A tumor-borne Angpt2/Tie2 autostimulatory loop controls tumorigenesis (2022) (0)
- P01.03FUNCTIONAL CHARACTERISATION OF THE ISOCITRATE DEHYDROGENASE 1 (IDH 1) R132H MUTATION IN GLIOMAS (2014) (0)
- Editorial: The adrenal gland: central relay in health and disease (2019) (0)
- Sympathetic cardioneuropathy in dysautonomias. (1997) (0)
- 24 CARDIAC SYMPATHETIC DENERVATION PRECEDING PARKINSON DISEASE. (2006) (0)
- Understanding Catecholamine Metabolism as a Guide for Assessment of Sympathoadrenal Function and Dysfunction in Health and Disease (2014) (0)
- Preface (2002) (0)
- tandem mass spectrometry : utility for diagnosis of dopamine-producing metastatic − chromatography Analysis of plasma 3-methoxytyramine , normetanephrine and metanephrine by ultraperformance liquid (2013) (0)
- Increased voluntary ethanol intake after dietary salt-loading in rats (1986) (0)
- Comparability of steroid hormone measurement among 9 European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS): Impact of the blood derivative and of calibration (2020) (0)
- Role of microenvironment on metabolic control of murine pheochromocytoma SDHB silenced cells (2017) (0)
- The Adrenal Medulla (2002) (0)
- Inhibition of uptake‐1 activity in the human heart in a hypernoradrenergic state (2004) (0)
- HIF-2[alpha] is detrimental for the functioning of the adrenal medulla (2022) (0)
- Influence of a mineralocorticoid receptor blockade on vascular function in atherosclerotic mouse models under high-fat diet (2014) (0)
- Abstracts of the 15th International VHL Medical/Research Symposium (2022) (0)
- Case 8-2018: A Woman with Shock and Labile Blood Pressure. (2018) (0)
- Cardiac Sympathetic Denervation Preceding Parkinson Disease (2006) (0)
- Chapter 91 – Monoamine Oxidase Deficiency (2012) (0)
- OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization (2018) (0)
- EXTENSIVE CLINICAL EXPERIENCE Clinical Presentations, Biochemical Phenotypes, and Genotype-Phenotype Correlations in Patients with Succinate Dehydrogenase Subunit B-Associated Pheochromocytomas and Paragangliomas (2007) (0)
- Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment (2021) (0)
- Die Diagnose des Phäochromozytoms und Paraganglioms (2013) (0)
- STANDARD UND FORTSCHRITT 45 Diagnostik des Phäochromozytoms (2000) (0)
- Abstractband zum 118. Kongress der DGIM 2012 (2012) (0)
- Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism (0)
- INCREASED CARDIAC SYMPATHETIC ACTIVITY IN HYPERTENSIVE PATIENTS WITH RENOVASCULAR DISEASE: P2.193 (2000) (0)
- Biochemical diagnosis of pheochromocytoma by measurements of overnight excretion levels of catecholamines and metabolites as a simplified alternative to 24-hour collections (2015) (0)
- Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma (2023) (0)
- TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas (2022) (0)
- Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses. (2023) (0)
- TITLE: Targeted exome sequencing of Krebs cycle genes reveals candidate cancer predisposing mutations in pheochromocytomas and paragangliomas (2017) (0)
- Paroxysmal Hypertension: Pheochromocytoma (2018) (0)
- Pheochromocytoma : first international symposium (2006) (0)
- Adrenal medulla in CRHR type 1-deficient mice (2002) (0)
- Acknowledgement to Reviewers (1994) (0)
- Novel methods in adrenal research: a metabolomics approach (2019) (0)
- SDHB mutation testing in metastatic pheochromocytoma and paraganglioma: Is this required in patients with adrenaline-producing tumors? (2014) (0)
- Abstract LB-308: Effects of the IDH1 R132H mutation on redox status and metabolism are cell type dependent but independent from D-2-hydroxyglutarate accumulation (2016) (0)
- Utility of urinary free catecholamines and their O-methylated metabolites for diagnosis of pheochromocytoma in comparison to total urinary metanephrines (2013) (0)
- Machine Learning models for the accurate prediction of malignant pheochromocytomas and paragangliomas (2022) (0)
- Impact of mineralocorticoid receptor blockade on vascular function in atherosclerotic mouse models under high-fat diet (2014) (0)
- 114 Plasma metanephrines in the diagnosis of pheochromocytoma (1993) (0)
- Is steroid profiling using LC-MS/MS useful in the diagnostic work-up of primary aldosteronism? (2016) (0)
- Abstract 3391: Next generation sequencing paves the way for personalized medicine in pheochromocytoma and paraganglioma patients and their families (2017) (0)
- Vitamin C Transporter Knock-out Leads to Severe Impairment of Adrenal Function (2004) (0)
- Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells (2012) (0)
- The asymmetric adrenal in mice and men: Sexual dimorphism and potential hormonal consequences (2022) (0)
- Cornea Farinata and other Variants (2009) (0)
- Tumor Metabolism and Metabolomics of Pheochromocytomas and Paragangliomas (2017) (0)
- [68Ga]Ga-DATATOC imaging, biodistribution and kinetics in a pheochromocytoma model (2015) (0)
- Autonomic Nervous System Function in Rheumatoid Arthritis (2012) (0)
- LAB-METABOLIC PATHWAYS (2012) (0)
- Abstract A159: Epigenetic silencing of the M-type phospholipase A2 receptor gene in leukemic cells. (2011) (0)
- reviewPheochromocytoma and Paraganglioma syndromes : going on 2010 (2010) (0)
- Metanephrines: Plasma or Urine (2019) (0)
- 19. Renal extractions of endogenous and tritiated norepinephrine and epinephrine in patients with cardio‐renal disorders and in healthy volunteers (1995) (0)
- OR02-6 Mass Spectrometry-Based Steroid Profiling Inprimary Bilateral Macronodular Adrenocortical Hyperplasia (2019) (0)
- The Effect of Working in a Children's Hospital on Urinary Catecholamine Excretion Rates in Male and Female Physicians (2014) (0)
- Evaluation of Pheochromocytoma and Paraganglioma (2014) (0)
- Abstract 16549: Eplerenone and Vascular Function in LOX-1 Overexpressing Mice on High-Fat Diet (2017) (0)
- Leichtbauer und Mediziner entwickeln Versuchsgerät für verbesserte Tumordiagnose (2016) (0)
- Pheochromocytoma and paraganglioma syndromes: going on 2010 (2010) (0)
- Role of microenvironment on proliferation and migration of an SDHB silenced murine Pheochromocytoma cell line (2017) (0)
- Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. (2022) (0)
- Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. (2023) (0)
- Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals (2014) (0)
- Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Graeme Eisenhofer?
Graeme Eisenhofer is affiliated with the following schools:
